Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.00 (-0.10%)
Close on Nov 18, 2026Market cap $41.52MP/E –Yield –
Talphera free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Talphera's free cash flow for the twelve months ending Dec 31, 2024 was -$12.68M. For fiscal 2024 it was -$12.68M. The highest annual figure on record is -$3.77M in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$12.68M | – |
| FY2023 | Dec 31, 2023 | -$17.59M | – |
| FY2022 | Dec 31, 2022 | -$28.70M | – |
| FY2021 | Dec 31, 2021 | -$31.83M | – |
| FY2020 | Dec 31, 2020 | -$40.36M | – |
| FY2019 | Dec 31, 2019 | -$54.65M | – |
| FY2018 | Dec 31, 2018 | -$29.89M | – |
| FY2017 | Dec 31, 2017 | -$32.17M | – |
| FY2016 | Dec 31, 2016 | -$33.12M | – |
| FY2015 | Dec 31, 2015 | -$21.41M | – |
| FY2014 | Dec 31, 2014 | -$39.96M | – |
| FY2013 | Dec 31, 2013 | -$3.77M | – |
| FY2012 | Dec 31, 2012 | -$25.41M | – |
| FY2011 | Dec 31, 2011 | -$17.31M | – |
| FY2010 | Dec 31, 2010 | -$12.23M | – |
| FY2009 | Dec 31, 2009 | -$19.53M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$2.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.95M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.35M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.02M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.94M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.73M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.96M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.18M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.79M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$12.90M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.45M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.90M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.24M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.59M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.59M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$10.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.07M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.15M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.19M | – |
See a number that looks wrong?